Correction to Novartis CEO story

Date : 02/19/2018 @ 7:31AM
Source : Dow Jones News
Stock : Novartis Ag (NVS)
Quote : 77.3356  0.9156 (1.20%) @ 2:48PM
Novartis share price Chart

Correction to Novartis CEO story

Novartis (NYSE:NVS)
Historical Stock Chart

3 Months : From Jan 2018 to Apr 2018

Click Here for more Novartis Charts.

Dr. Narasimhan, a U.S. citizen of Indian descent, joined Novartis in 2005 from consultancy McKinsey & Co., and rose quickly through the Swiss drugmaker's ranks to become chief medical officer and global head of drug development. "Novartis CEO Steers Drug Maker Back to R&D," at 09:02 GMT, incorrectly said Dr. Narasimhan is a U.S. citizen of Indian descent. A previous version of this story incorrectly said he was born in India. Dr. Narasimhan was Novartis' chief medical officer and global head of drug development. The earlier version of the story incorrectly said he was head of the company's research and development.

 

(END) Dow Jones Newswires

February 19, 2018 07:16 ET (12:16 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.

Latest NVS Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V:us D:20180426 19:03:57